A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - February 15, 2024 Category: Cancer & Oncology Authors: Gregory J Riely Egbert F Smit Myung-Ju Ahn Enriqueta Felip Suresh S Ramalingam Anne Tsao Melissa Johnson Francesco Gelsomino Raymond Esper Ernest Nadal Michael Offin Mariano Provencio Jeffrey Clarke Maen Hussein Gregory A Otterson Ibiayi Dagogo-Jack Jonat Source Type: research